GPCR logo

GPCRStructure Therapeutics Inc - ADR

$40.02
$2.25
(5.96%)
Today
Updated: 01:14 PM EDT
EarningsAug 6
Mkt Cap$2.68B
Vol1.09M

About

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
220

Frequently Asked Questions

What is Market Cap of Structure Therapeutics Inc - ADR?
What is the 52-week high for Structure Therapeutics Inc - ADR?
What is the 52-week low for Structure Therapeutics Inc - ADR?
What is Structure Therapeutics Inc - ADR stock price today?
What was Structure Therapeutics Inc - ADR stock price yesterday?
What is the PE ratio of Structure Therapeutics Inc - ADR?
What is the Price-to-Book ratio of Structure Therapeutics Inc - ADR?
What is the 50-day moving average of Structure Therapeutics Inc - ADR?
How many employees does Structure Therapeutics Inc - ADR have?

Advertisement|Remove ads.